Frenkel Nanne J, Vogt Liffert, De Rooij Sophia E, Trimpert Christiane, Levi Marcel M, Deen Peter M T, van den Born Bert-Jan H
aDivision of Internal and Vascular Medicine bDivision of Nephrology cDivision of Geriatrics, Department of Internal Medicine, Academic Medical Center, Amsterdam dDepartment of Physiology, Nijmegen Centre of Molecular Life Science, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
J Hypertens. 2015 Mar;33(3):627-33. doi: 10.1097/HJH.0000000000000423.
Hyponatraemia is a common, potentially life-threatening, complication of thiazide diuretics. The mechanism of thiazide-induced hyponatraemia is incompletely understood. Previous experiments have suggested a direct effect of thiazide diuretics on the plasma membrane expression of aquaporin (AQP)2.
We examined the effects of a single re-exposure to hydrochlorothiazide (HCTZ) 50 mg on water balance, renal sodium handling and osmoregulation in 15 elderly hypertensive patients with a history of thiazide-induced hyponatraemia and 15 matched hypertensive controls using thiazide diuretics without previous hyponatraemia.
Patients with thiazide-induced hyponatraemia had significantly lower body weight and lower plasma sodium and osmolality at baseline. After HCTZ administration, plasma sodium and osmolality significantly decreased and remained lower in patients compared with controls (P < 0.001). Plasma antidiuretic hormone (ADH) and urine AQP2 were low or suppressed in patients, whereas solute and electrolyte-free water clearance was significantly increased compared with controls. Ad libitum water intake was significantly higher in patients (2543 ± 925 ml) than in controls (1828 ± 624 ml, P < 0.05), whereas urinary sodium excretion did not differ. In contrast, urea excretion remained significantly lower in patients (263 ± 69 mmol per 24 h) compared with controls (333 ± 97 mmol per 24 h, P < 0.05) and predicted the decrease in plasma sodium following HCTZ administration.
Thiazide diuretics are associated with markedly impaired free water excretion at low ADH and AQP2 in elderly patients. The higher water intake and lower urea excretion in patients points to an important role for polydipsia and urea-mediated water excretion in the pathogenesis of thiazide-induced hyponatraemia.
低钠血症是噻嗪类利尿剂常见的、潜在危及生命的并发症。噻嗪类药物所致低钠血症的机制尚不完全清楚。既往实验提示噻嗪类利尿剂对水通道蛋白(AQP)2的质膜表达有直接作用。
我们使用噻嗪类利尿剂且无既往低钠血症病史,研究了单次再次给予50mg氢氯噻嗪(HCTZ)对15例有噻嗪类药物所致低钠血症病史的老年高血压患者及15例匹配的无既往低钠血症的高血压对照者的水平衡、肾脏钠处理及渗透压调节的影响。
有噻嗪类药物所致低钠血症的患者基线时体重明显较低,血浆钠和渗透压也较低。给予HCTZ后,患者的血浆钠和渗透压显著降低,且与对照组相比仍较低(P<0.001)。患者的血浆抗利尿激素(ADH)和尿AQP2较低或受抑制,而与对照组相比,溶质和无电解质水清除率显著增加。患者的随意饮水量(2543±925ml)显著高于对照组(1828±624ml,P<0.05),而尿钠排泄无差异。相比之下,患者的尿素排泄(每24小时263±69mmol)与对照组(每24小时333±97mmol,P<0.05)相比仍显著较低,并可预测给予HCTZ后血浆钠的降低。
噻嗪类利尿剂与老年患者在低ADH和AQP2水平时自由水排泄明显受损有关。患者较高的饮水量和较低的尿素排泄表明烦渴和尿素介导的水排泄在噻嗪类药物所致低钠血症的发病机制中起重要作用。